These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10942401)

  • 1. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis.
    Roboz GJ; Dias S; Lam G; Lane WJ; Soignet SL; Warrell RP; Rafii S
    Blood; 2000 Aug; 96(4):1525-30. PubMed ID: 10942401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer.
    Xiao YF; Liu SX; Wu DD; Chen X; Ren LF
    World J Gastroenterol; 2006 Sep; 12(36):5780-6. PubMed ID: 17007042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
    Sturlan S; Baumgartner M; Roth E; Bachleitner-Hofmann T
    Blood; 2003 Jun; 101(12):4990-7. PubMed ID: 12609832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells.
    Mohammadi Kian M; Mohammadi S; Tavallaei M; Chahardouli B; Rostami S; Zahedpanah M; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1127-1134. PubMed ID: 29699374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.
    Yuksel S; Saydam G; Uslu R; Sanli UA; Terzioglu E; Buyukececi F; Omay SB
    Leuk Res; 2002 Apr; 26(4):391-8. PubMed ID: 11839383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide.
    Zhang Y; Shen WL
    Cell Biol Int; 2003; 27(12):953-8. PubMed ID: 14642526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFA Expression Is Inhibited by Arsenic Trioxide in HUVECs through the Upregulation of Ets-2 and miRNA-126.
    Ge HY; Han ZJ; Tian P; Sun WJ; Xue DX; Bi Y; Yang ZH; Liu P
    PLoS One; 2015; 10(8):e0135795. PubMed ID: 26274316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
    Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
    Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
    Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S
    Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
    Sordet O; Rébé C; Leroy I; Bruey JM; Garrido C; Miguet C; Lizard G; Plenchette S; Corcos L; Solary E
    Blood; 2001 Jun; 97(12):3931-40. PubMed ID: 11389037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
    Altman JK; Yoon P; Katsoulidis E; Kroczynska B; Sassano A; Redig AJ; Glaser H; Jordan A; Tallman MS; Hay N; Platanias LC
    J Biol Chem; 2008 Jan; 283(4):1992-2001. PubMed ID: 18048359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.
    Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC
    Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma.
    Wang Y; Hu Y; Sun C; Zhang X; He W
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):43-6. PubMed ID: 16711005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
    Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.
    Yedjou CG; Moore P; Tchounwou PB
    Int J Environ Res Public Health; 2006 Jun; 3(2):136-40. PubMed ID: 16823087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various tolerances to arsenic trioxide between human cortical neurons and leukemic cells.
    Zhou J; Meng R; Sui X; Li W; Yang B
    Sci China C Life Sci; 2006 Dec; 49(6):567-72. PubMed ID: 17312995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
    Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S
    Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
    Davison K; Mann KK; Waxman S; Miller WH
    Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.